Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Trumenba Global Market Report 2025
Request Sample Buy Now
Global Trumenba Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Trumenba Global Market Report 2025

By Clinical Indication (Meningococcal Disease Prevention, High-Risk Populations, Adolescents And Young Adults, Post-Exposure Vaccination), By Distribution Channel (Hospital And Clinics, Retail Pharmacies, Specialty Pharmacies), By End-User (Hospitals, Clinics, Research Institutes, Ambulatory Surgical Centers, Other End-Users)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Trumenba Market?

Trumenba is a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B. It is a meningococcal group B vaccine (recombinant) that stimulates the immune system to produce antibodies against serogroup B bacteria, helping to protect individuals from potentially life-threatening infections such as meningitis and bloodstream infections.

The main types of clinical indications in trumenba are meningococcal disease prevention, high-risk populations, adolescents and young adults, and post-exposure vaccination. Meningococcal disease prevention refers to the measures taken to reduce the risk of infection from Neisseria meningitidis, such as vaccination, early detection, and prompt antibiotic treatment. It is distributed through various channels such as hospitals and clinics, retail pharmacies, and specialty pharmacies. catering to various end users such as hospitals, clinics, research institutes, ambulatory surgical centers, and others

Trumenba Market Size and growth rate 2025 to 2029: Graph

What Is The Trumenba Market Size 2025 And Growth Rate?

The trumenba market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to public health awareness, increasing incidence of meningococcal disease, government support and initiatives, rising immunization rates, and increasing pediatric population.

What Is The Trumenba Market Growth Forecast?

The trumenba market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing levels of vaccination coverage, rising focus on preventive healthcare, rising burden of chronic diseases, expansion of healthcare infrastructure, and increasing immunization programs. Major trends in the forecast period include advancements in vaccine technology, development of new vaccine formulations, advancements in immunization strategies, advancements in dosing schedules, and technological advancements in vaccine delivery.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

How Is The Trumenba Market Segmented?

The trumenba market covered in this report is segmented –

1) By Clinical Indication: Meningococcal Disease Prevention; High-Risk Populations; Adolescents And Young Adults; Post-Exposure Vaccination

2) By Distribution Channel: Hospital And Clinics; Retail Pharmacies; Specialty Pharmacies

3) By End-User: Hospitals; Clinics; Research Institutes; Ambulatory Surgical Centers; Other End-Users

What Is Driving The Trumenba Market? Rising Incidence Of Meningococcal Disease Drives Growth Of The Market

The growing incidence of meningococcal disease is expected to propel the growth of the trumenba market going forward. Meningococcal is a type of bacterial infection caused by Neisseria meningitidis, which leads to serious illnesses such as meningitis and bloodstream infections. The incidence of meningococcal disease is due to bacterial transmission, environmental factors, and limited vaccination coverage, leading to more significant investments in preventive measures and healthcare infrastructure globally. Trumenba reduces the risk of invasive meningococcal diseases, such as meningitis and bloodstream infections, by providing immunity against Neisseria meningitidis serogroup B. For instance, in August 2024, according to the Meningococcal Reference Unit (MRU), a UK-based organization that provides services and resources related to meningococcal disease, there were 396 cases of invasive meningococcal disease (IMD) in 2022 to 2023, compared to 205 cases in 2021 to 2022. Therefore, the growing incidence of meningococcal disease drives growth in the trumenba market.

What Is Driving The Trumenba Market? Growing Vaccination Coverage Driving The Market Growth

The growing levels of vaccination coverage are expected to propel the growth of the trumenba market going forward. Vaccination is administering a vaccine to stimulate the immune system and provide protection against specific diseases. The growing levels of vaccination coverage are due to increased access, public awareness campaigns, and improved healthcare systems, leading to higher immunization rates and better disease prevention. Trumenba is useful for vaccination by providing targeted protection against Neisseria meningitidis serogroup B, helping reduce the risk of invasive meningococcal disease, and improving vaccination coverage for at-risk individuals. For instance, in July 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2023, around 37 countries adopted a 1-dose HPV vaccination schedule, covering over 45% of vaccinated girls aged 9–14. Further, the global first-dose HPV vaccine coverage among girls increased from 20% in 2022 to 27% in 2023, progressing toward the 90% target for 2030. Therefore, the growing levels of vaccination coverage are driving growth in the trumenba market.

Who Are The Major Players In The Global Trumenba Market?

Major companies operating in the trumenba market are Pfizer Inc.

What Are The Key Trends Of The Global Trumenba Market? Trumenba Market Advances In Protection Against Multiple Meningococcal Serogroups

The key trend in the trumenba market is developing combination vaccines, such as pentavalent meningococcal vaccines, to broaden immunization coverage and enhance protection against multiple serogroups of Neisseria meningitidis. A pentavalent meningococcal vaccine protects against five different serogroups of Neisseria meningitidis, typically A, C, W, Y, and B, to offer broader immunity against meningococcal infections. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company, received Food and Drug Administration (FDA) approval for PENBRAYA, a groundbreaking pentavalent meningococcal vaccine. This vaccine, a combination of two established meningococcal vaccines, Trumenba and Nimenrix, is the first of its kind to protect against five major meningococcal serogroups (A, B, C, W, and Y), which are responsible for the majority of invasive meningococcal diseases globally. Targeted at adolescents and young adults aged 10 to 25, PENBRAYA strengthens Pfizer's portfolio in the vaccine space, offering enhanced protection against a widespread and potentially fatal disease.

Need data on a specific region in this market?
Request Customisation

Regional Analysis For The Global Trumenba Market

North America was the largest region in the trumenba market in 2024. The regions covered in the trumenba market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the trumenba market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Trumenba Market?

The trumenba market consists of sales of monovalent, combination vaccines, the trumenba 2-dose regimen, booster doses, and nimenrix. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Trumenba Industry?

The trumenba market research report is one of a series of new reports from The Business Research Company that provides trumenba market statistics, including the trumenba industry global market size, regional shares, competitors with the trumenba market share, detailed trumenba market segments, market trends, and opportunities, and any further data you may need to thrive in the trumenba industry. This trumenba market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Trumenba Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The trumenba market covered in this report is segmented –
1) By Clinical Indication: Meningococcal Disease Prevention; High-Risk Populations; Adolescents And Young Adults; Post-Exposure Vaccination
2) By Distribution Channel: Hospital And Clinics; Retail Pharmacies; Specialty Pharmacies
3) By End-User: Hospitals; Clinics; Research Institutes; Ambulatory Surgical Centers; Other End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Trumenba Market Characteristics

3. Trumenba Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Trumenba Market Trends And Strategies

5. Trumenba Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Trumenba Growth Analysis And Strategic Analysis Framework

6.1. Global Trumenba PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Trumenba Market Growth Rate Analysis

6.4. Global Trumenba Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Trumenba Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Trumenba Total Addressable Market (TAM)

7. Global Trumenba Pricing Analysis & Forecasts

8. Trumenba Market Segmentation

8.1. Global Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Meningococcal Disease Prevention

High-Risk Populations

Adolescents And Young Adults

Post-Exposure Vaccination

8.2. Global Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital And Clinics

Retail Pharmacies

Specialty Pharmacies

8.3. Global Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Clinics

Research Institutes

Ambulatory Surgical Centers

Other End-Users

9. Global Trumenba Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Trumenba Market Regional And Country Analysis

10.1. Global Trumenba Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Trumenba Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Trumenba Market

11.1. Asia-Pacific Trumenba Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Trumenba Market

12.1. China Trumenba Market Overview

12.2. China Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Trumenba Market

13.1. India Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Trumenba Market

14.1. Japan Trumenba Market Overview

14.2. Japan Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Trumenba Market

15.1. Australia Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Trumenba Market

16.1. South Korea Trumenba Market Overview

16.2. South Korea Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Trumenba Market

17.1. Western Europe Trumenba Market Overview

17.2. Western Europe Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Trumenba Market

18.1. UK Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Trumenba Market

19.1. Germany Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Trumenba Market

20.1. France Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Trumenba Market

21.1. Eastern Europe Trumenba Market Overview

21.2. Eastern Europe Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Trumenba Market

22.1. North America Trumenba Market Overview

22.2. North America Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Trumenba Market

23.1. USA Trumenba Market Overview

23.2. USA Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Trumenba Market

24.1. Canada Trumenba Market Overview

24.2. Canada Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Trumenba Market

25.1. South America Trumenba Market Overview

25.2. South America Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Trumenba Market

26.1. Middle East Trumenba Market Overview

26.2. Middle East Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Trumenba Market

27.1. Africa Trumenba Market Overview

27.2. Africa Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Trumenba Market Competitive Landscape And Company Profiles

28.1. Trumenba Market Competitive Landscape

28.2. Trumenba Market Company Profiles

28.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Trumenba Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Trumenba Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Trumenba Market

32. Recent Developments In The Trumenba Market

33. Trumenba Market High Potential Countries, Segments and Strategies

33.1 Trumenba Market In 2029 - Countries Offering Most New Opportunities

33.2 Trumenba Market In 2029 - Segments Offering Most New Opportunities

33.3 Trumenba Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Trumenba Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Trumenba Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Trumenba Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Trumenba Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Trumenba Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Trumenba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Trumenba Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Pfizer Inc. Financial Performance

2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

Read More About Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

Read More About CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Monoclonal Antibodies (MAs) Global Market Report 2025 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardio...

View Report

Antibody Drug Conjugates Global Market Report 2025 – By Type (Monoclonal Antibodies, Linker, Drug/Toxin, Other Types), By Product (Adcertis, Kadcyla, Other Products), By Technology (Immunogen Technology, Seattle Genetics...

View Report

Biosimilar Monoclonal Antibodies Global Market Report 2025 – By Type (Synthetic Chemicals, Biopharmaceuticals, Other Types), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), By Applic...

View Report

Research Antibodies and Reagents Global Market Report 2025 – By Technology (Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (Elisa), Others), By Application (Prot...

View Report

Conjugated Monoclonal Antibodies Global Market Report 2025 – By Drugs (Adcetris, Kadcyla), By Technology (Cleavable Linker, Non-cleavable Linker), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer,...

View Report

Arthritis Monoclonal Antibodies Global Market Report 2025 – By Drug (Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthrit...

View Report

Breast Cancer Monoclonal Antibodies Global Market Report 2025 – By Product (Naked Mabs, Conjugated Mabs), By Treatment (Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Therapy), By ...

View Report

Cancer Monoclonal Antibodies Global Market Report 2025 – By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain...

View Report

Frequently Asked Questions

Trumenba is a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B. It is a meningococcal group B vaccine (recombinant) that stimulates the immune system to produce antibodies against serogroup B bacteria, helping to protect individuals from potentially life-threatening infections such as meningitis and bloodstream infections. For further insights on the Trumenba market, request a sample here

The Trumenba market major growth driver - Rising Incidence Of Meningococcal Disease Drives Growth Of The Market. For further insights on the Trumenba market, request a sample here

The Trumenba market size has grown strongly in recent years. The trumenba market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to public health awareness, increasing incidence of meningococcal disease, government support and initiatives, rising immunization rates, and increasing pediatric population. The trumenba market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing levels of vaccination coverage, rising focus on preventive healthcare, rising burden of chronic diseases, expansion of healthcare infrastructure, and increasing immunization programs. Major trends in the forecast period include advancements in vaccine technology, development of new vaccine formulations, advancements in immunization strategies, advancements in dosing schedules, and technological advancements in vaccine delivery. For further insights on the Trumenba market, request a sample here

The trumenba market covered in this report is segmented –
1) By Clinical Indication: Meningococcal Disease Prevention; High-Risk Populations; Adolescents And Young Adults; Post-Exposure Vaccination
2) By Distribution Channel: Hospital And Clinics; Retail Pharmacies; Specialty Pharmacies
3) By End-User: Hospitals; Clinics; Research Institutes; Ambulatory Surgical Centers; Other End-Users For further insights on the Trumenba market, request a sample here

North America was the largest region in the trumenba market in 2024. The regions covered in the trumenba market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Trumenba market, request a sample here.

Major companies operating in the trumenba market are Pfizer Inc. . For further insights on the Trumenba market, request a sample here.

Major trends in the Trumenba market include Trumenba Market Advances In Protection Against Multiple Meningococcal Serogroups. For further insights on the Trumenba market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Trumenba Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top